Coronavirus pandemic | Capgemini India gives salary hike to 70% staff, retains employees on bench

Ashwin Yardi, CEO of Capgemini India, has assured that all employees will receive their full salaries regardless of their bench time

Moneycontrol News

April 15, 2020 / 13:31 IST

In a welcome move, French IT major Capgemini has announced that it has given single-digit salary hike to 70 percent of its employees in India, effective April 1, 2020. The tech firm has 1.2 lakh employees in India, of which 84,000 employees will be benefitted by this decision.

The rest of the employees of Capgemini India will get their increments in July, reported the Times of India. The decision has been praised widely, especially since several companies have cut the salaries of their employees or sacked their staff to deal with the COVID-19 crisis that has brought economic activity to a standstill.

For live updates on coronavirus, click here

Notably, the IT company will also be providing cash allowance of up to Rs 10,000 to employees who have got stranded due to the nationwide lockdown to curb the spread of the novel coronavirus and do not have a paying-guest accommodation either. These decisions were taken by the company at a meeting held in mid-March before the lockdown had been announced.

Coronavirus pandemic | Mental illness cases rise in India after COVID-19 outbreak: Study

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Coronavirus pandemic | Capgemini India gives salary hike to 70% staff, retains employees on bench

Ashwin Yardi, CEO of Capgemini India, has assured that all employees will receive their full salaries regardless of their bench time

Related stories

Subscribe to Tech Newsletters

Coronavirus pandemic | Capgemini India gives salary hike to 70% staff, retains employees on bench

Ashwin Yardi, CEO of Capgemini India, has assured that all employees will receive their full salaries regardless of their bench time

Related stories

Subscribe to Tech Newsletters

Trending news